Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25726671 | 0.87 | CYP2D6 (0.36) | — | |
| SCHEMBL15806527 | 0.85 | TSHR (0.32) | TSHRMAPK1 | |
| SCHEMBL6141036 | 0.83 | — | — | |
| SCHEMBL20130263 | 0.83 | MEN1 (0.33) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL23415583 | 0.82 | — | — | |
| SCHEMBL15803969 | 0.80 | TSHR (0.34) | TSHR | |
| SCHEMBL18250965 | 0.79 | MEN1 (0.31) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL3224210 | 0.79 | — | — | |
| SCHEMBL15803975 | 0.78 | GSTP1 (0.42) | TSHR | |
| SCHEMBL23415572 | 0.78 | CA2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180126011-A1 | DENDRI-TAC AND THEIR USE AS THERANOSTICS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2018-05-10 | — | — | US | disclosed |
| US-20140170405-A1 | PROCESSES FOR PREPARING CURED FILMS, THE RESULTING FILMS, AND PLASMA-INITIATED POLYMERIZABLE COMPOSITIONS | FUJIFILM CORPORATION (JP) | 2014-06-19 | — | — | US | disclosed |
| EP-0534465-B1 | Curable resin composition | NIPPON PAINT CO LTD (JP) | 1997-08-27 | — | — | EP | disclosed |
| US-5324807-A | Resin having a plurality of alkynyl groups, an organohydrogenpolysiloxane and a platimum catalyst | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-06-28 | — | — | US | disclosed |
| EP-0534465-A2 | Curable resin composition | NIPPON PAINT COMPANY LIMITED (JP) | 1993-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180126011-A1 | DENDRI-TAC AND THEIR USE AS THERANOSTICS | DBI, CDIPT, DGKI | TSHR 973/4885MAPK1 4821/4885MEN1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.